Final Results -2 -13-
30 Março 2009 - 3:01AM
UK Regulatory
+----------------------------------------------+------------+------------+
| Opening balance | 293,506 | - |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
| Transfer from share | - | 293,506 |
| premium | | |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
| Balance at 31 December | 293,506 | 293,506 |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
33. Retained earnings
+----------------------------------------------+------------+------------+
| | 31 Dec | 31 Dec |
| | 2008 | 2007 |
| | GBP'000s | GBP'000s |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
| Opening balance | 7,175 | 1,616 |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
| Dividends paid | (17,992) | (10,050) |
+----------------------------------------------+------------+------------+
| Net profit for the year | 10,015 | 15,609 |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
| Balance at 31 December | (802) | 7,175 |
+----------------------------------------------+------------+------------+
| | | |
+----------------------------------------------+------------+------------+
34. Acquisition of subsidiaries
+-------------------------------+----------+----------+-----------+----------+----------+
| |Maesteg1 |Diabolo2 | Orange | RCH4 | Total |
| |GBP'000s |GBP'000s |Hospital3 |GBP'000s |GBP'000s |
| | | | GBP'000s | | |
+-------------------------------+----------+----------+-----------+----------+----------+
| Assets | | | | | |
+-------------------------------+----------+----------+-----------+----------+----------+
| Intangible assets | 2,688 | 87,495 | 6,551 | 32,279 | 129,013 |
+-------------------------------+----------+----------+-----------+----------+----------+
| Financial assets - available | 14,175 | 8,414 | 7,045 | 38,796 | 68,430 |
| for sale | | | | | |
+-------------------------------+----------+----------+-----------+----------+----------+
| Trade and other receivables | 335 | 3,333 | 2,412 | 917 | 6,997 |
+-------------------------------+----------+----------+-----------+----------+----------+
| Cash and cash equivalents | 211 | 371 | 80,765 | 654,996 | 736,343 |
+-------------------------------+----------+----------+-----------+----------+----------+
| Deferred tax asset | 7 | 2,863 | 383 | 39 | 3,292 |
+-------------------------------+----------+----------+-----------+----------+----------+
| Derivative financial | 67 | - | - | 6,581 | 6,648 |
| instruments | | | | | |
+-------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+-------------------------------+----------+----------+-----------+----------+----------+
| Total Assets acquired | 17,483 | 102,476 | 97,156 | 733,608 | 950,723 |
+-------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+-------------------------------+----------+----------+-----------+----------+----------+
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | Maesteg1 | Diabolo2 | Orange | RCH4 | Total |
| | | |Hospital3 | | GBP'000s |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Liabilities | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Trade and other payables | 893 | 641 | 554 | 932 | 3,020 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Bank loans and bonds | 12,049 | 28,974 | 80,464 | 669,482 | 790,969 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Deferred tax liabilities | 773 | 23,472 | 2,330 | 9,684 | 36,259 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Short term provisions | - | 790 | - | - | 790 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Current tax liabilities | - | - | - | 255 | 255 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Derivative financial | - | 5,719 | - | 8,316 | 14,035 |
| liabilities | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Total Liabilities acquired | 13,715 | 59,596 | 83,348 | 688,669 | 845,328 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Net Book Value | 3,768 | 42,880 | 13,808 | 44,939 | 105,395 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Minority | - | (13,981) | - | - | (13,981) |
| share of | | | | | |
| net | | | | | |
| assets | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Net Book Value | 3,768 | 28,899 | 13,808 | 44,939 | 91,414 |
| attributable to | | | | | |
| shareholders | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Total consideration | 3,768 | 28,899 | 13,808 | 44,939 | 91,414 |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| | | | | | |
+---------------------------------------------+----------+----------+-----------+----------+----------+
| Net cash inflow/(outflow) on | | | | | |
Babcock & Brown (See LSE:BBPP) (LSE:BBPP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Babcock & Brown (See LSE:BBPP) (LSE:BBPP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024